HEADER TOXIN 12-JUL-12 4B1Q TITLE NMR STRUCTURE OF THE GLYCOSYLATED CONOTOXIN CCTX FROM CONUS CONSORS CAVEAT 4B1Q GAL A 2 HAS WRONG CHIRALITY AT ATOM C1 GXL A 5 HAS WRONG CAVEAT 2 4B1Q CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CONOTOXIN CCTX; COMPND 3 CHAIN: P; COMPND 4 SYNONYM: EXCITOTOXIN CCTX, KAPPAA-CONOTOXIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CONUS CONSORS; SOURCE 3 ORGANISM_TAXID: 101297 KEYWDS TOXIN, O-GLYCAN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR H.G.HOCKING,G.J.GERWIG,P.FAVREAU,R.STOCKLIN,J.P.KAMERLING,R.BOELENS REVDAT 2 29-JUL-20 4B1Q 1 CAVEAT COMPND REMARK HETNAM REVDAT 2 2 1 LINK SITE ATOM REVDAT 1 06-FEB-13 4B1Q 0 JRNL AUTH H.G.HOCKING,G.J.GERWIG,S.DUTERTRE,A.VIOLETTE,P.FAVREAU, JRNL AUTH 2 R.STOCKLIN,J.P.KAMERLING,R.BOELENS JRNL TITL STRUCTURE OF THE O-GLYCOSYLATED CONOPEPTIDE CCTX FROM CONUS JRNL TITL 2 CONSORS VENOM. JRNL REF CHEMISTRY V. 19 870 2013 JRNL REFN ISSN 0947-6539 JRNL PMID 23281027 JRNL DOI 10.1002/CHEM.201202713 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT IN EXPLICIT WATER SOLVENT REMARK 4 REMARK 4 4B1Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1290052641. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 292.0 REMARK 210 PH : 3.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 95 % H2O/ 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; TOCSY; COSY; H2BC REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR ANALYSIS ANALYSIS REMARK 210 METHOD USED : CYANA AND CNS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING NOE RESTRAINTS REMARK 210 ORIGINATING FROM BOTH THE PEPTIDE AND GLYCAN COMPONENTS OF THE REMARK 210 SYSTEM. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: P, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER P 7 -153.60 -89.03 REMARK 500 2 SER P 7 -156.02 -84.59 REMARK 500 2 TYR P 15 -96.83 -111.73 REMARK 500 2 ASN P 28 -7.00 82.46 REMARK 500 3 TYR P 15 -103.13 -86.77 REMARK 500 4 SER P 7 -150.59 -96.92 REMARK 500 4 TYR P 15 -88.65 -92.09 REMARK 500 5 SER P 7 -155.61 -84.23 REMARK 500 5 TYR P 15 -101.17 -102.68 REMARK 500 5 ASN P 28 -2.69 76.14 REMARK 500 6 SER P 7 -155.34 -88.36 REMARK 500 6 GLN P 8 80.65 -67.83 REMARK 500 6 TYR P 15 -154.77 -97.09 REMARK 500 7 SER P 7 -153.34 -94.35 REMARK 500 7 TYR P 15 -89.07 -94.24 REMARK 500 7 ASN P 28 30.68 72.73 REMARK 500 8 TYR P 15 -83.59 -92.93 REMARK 500 8 ASN P 28 30.01 72.38 REMARK 500 9 TYR P 15 -94.90 -97.13 REMARK 500 9 ASN P 28 -11.93 76.16 REMARK 500 10 HYP P 2 -159.17 -95.66 REMARK 500 10 SER P 7 -159.23 -83.84 REMARK 500 10 TYR P 15 -83.44 -100.20 REMARK 500 11 PRO P 6 -167.46 -78.59 REMARK 500 11 SER P 7 -157.10 -99.62 REMARK 500 11 TYR P 15 -80.34 -85.44 REMARK 500 11 CYS P 21 146.40 -173.11 REMARK 500 12 TYR P 15 -89.42 -88.81 REMARK 500 13 TYR P 15 -87.26 -81.84 REMARK 500 13 ASN P 28 -4.63 70.64 REMARK 500 14 PRO P 6 -168.04 -76.83 REMARK 500 14 GLN P 8 98.66 -63.18 REMARK 500 14 TYR P 15 -82.97 -87.22 REMARK 500 14 ASN P 28 10.19 82.14 REMARK 500 15 CYS P 12 98.25 -65.11 REMARK 500 15 TYR P 15 -85.51 -84.48 REMARK 500 15 ASN P 28 63.34 61.28 REMARK 500 15 THR P 29 129.56 166.37 REMARK 500 16 TYR P 15 -83.75 -90.63 REMARK 500 17 SER P 7 -159.00 -80.85 REMARK 500 17 TYR P 15 -85.56 -96.47 REMARK 500 18 SER P 7 -155.63 -86.39 REMARK 500 18 GLN P 8 94.10 -62.26 REMARK 500 18 TYR P 15 -96.66 -101.73 REMARK 500 19 SER P 7 -159.97 -89.41 REMARK 500 19 TYR P 15 -92.23 -92.38 REMARK 500 20 CYS P 12 97.46 -69.52 REMARK 500 20 TYR P 15 -94.78 -87.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18897 RELATED DB: BMRB DBREF 4B1Q P 1 30 UNP P58928 CEX_CONCN 1 30 SEQRES 1 P 30 ALA HYP TRP LEU VAL PRO SER GLN ILE THR THR CYS CYS SEQRES 2 P 30 GLY TYR ASN HYP GLY THR MET CYS HYP SER CYS MET CYS SEQRES 3 P 30 THR ASN THR CYS MODRES 4B1Q SER P 7 SER GLYCOSYLATION SITE MODRES 4B1Q HYP P 2 PRO 4-HYDROXYPROLINE MODRES 4B1Q HYP P 17 PRO 4-HYDROXYPROLINE MODRES 4B1Q HYP P 22 PRO 4-HYDROXYPROLINE HET HYP P 2 15 HET HYP P 17 15 HET HYP P 22 15 HET A2G A 1 26 HET GAL A 2 21 HET GXL A 3 22 HET NDG A 4 27 HET GXL A 5 22 HETNAM HYP 4-HYDROXYPROLINE HETNAM A2G 2-ACETAMIDO-2-DEOXY-ALPHA-D-GALACTOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM GXL ALPHA-L-GALACTOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETSYN HYP HYDROXYPROLINE FORMUL 1 HYP 3(C5 H9 N O3) FORMUL 2 A2G C8 H15 N O6 FORMUL 2 GAL C6 H12 O6 FORMUL 2 GXL 2(C6 H12 O6) FORMUL 2 NDG C8 H15 N O6 HELIX 1 1 HYP P 22 THR P 27 1 6 SSBOND 1 CYS P 12 CYS P 21 1555 1555 2.03 SSBOND 2 CYS P 13 CYS P 26 1555 1555 2.03 SSBOND 3 CYS P 24 CYS P 30 1555 1555 2.03 LINK C ALA P 1 N HYP P 2 1555 1555 1.34 LINK C HYP P 2 N TRP P 3 1555 1555 1.31 LINK OG SER P 7 C1 A2G A 1 1555 1555 1.42 LINK C ASN P 16 N HYP P 17 1555 1555 1.34 LINK C HYP P 17 N GLY P 18 1555 1555 1.33 LINK C CYS P 21 N HYP P 22 1555 1555 1.34 LINK C HYP P 22 N SER P 23 1555 1555 1.32 LINK O3 A2G A 1 C1 GAL A 2 1555 1555 1.42 LINK O6 A2G A 1 C1 NDG A 4 1555 1555 1.43 LINK O2 GAL A 2 C1 GXL A 3 1555 1555 1.43 LINK O4 NDG A 4 C1 GXL A 5 1555 1555 1.45 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1